Neo4j, the graph database from the US-Swedish company of the same name, is used by 76% of the Fortune 100, and its Australian customers include organisations in the healthcare, policing and banking ...
PocketOS was left scrambling after a rogue AI agent deleted swaths of code underpinning its business It only took nine seconds for an AI coding agent gone rogue to delete a company’s entire production ...
Finland’s Kone KNEBV2.35%increase; green up pointing triangle agreed to buy German rival TK Elevator for almost $24 billion in a deal that would create the world’s biggest elevator maker by sales.
Finland’s Kone has agreed to buy German rival TK Elevator in a landmark deal valued at 29.4 billion euros ($34.4 billion). The combination would create the world’s largest elevator maker and marks one ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
FBI Director Kash Patel says a trip to Italy that raised questions earlier in 2026 helped set the stage for the arrest of a Chinese national accused of hacking U.S. COVID-19 research. Xu Zewei is now ...
Kone’s class B shares are listed on Nasdaq Helsinki Advent and Cinven acquired TKE in 2020 The transaction resets Kone’s current long-term financial targets A consortium, led by Advent and Cinven, has ...
A €29.4 billion ($34.4 billion) cash-and-stock agreement to purchase TK Elevator was announced Tuesday by Finnish manufacturer Kone, which said the combined entity would rank as the world's top ...
HELSINKI, April 29 (Reuters) - Finnish lift maker Kone (KNEBV.HE), opens new tab has agreed to buy German rival TK Elevator (TKE) in a deal worth 29.4 billion euros ($34.4 billion) that would create ...
HELSINKI, April 29 (Reuters) - Finnish lift maker Kone has agreed to buy German rival TK Elevator (TKE) in a deal worth 29.4 billion euros ($34.4 billion) that would create the world's largest lift ...
A pandemic is a challenging but interesting moment for anyone involved in infectious disease, particularly those developing therapeutics and vaccines. That holds doubly true for Medicago, a Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results